Cronos Group Releases Cannabinoid Life Cycle Study Highlighting its Sustainable Fermentation Practices
April 21, 2023 07:00 ET
|
Cronos Group Inc.
TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today, in honor of Earth Day, released a Sustainability Study, which outlines the...
Cronos Bolsters its Spinach® Infused Pre-roll Portfolio with CBG, CBC and CBN
April 12, 2023 16:20 ET
|
Cronos Group Inc.
Spinach® rose to 8th place in the pre-roll category, capturing 2.5% market share in Q1 2023, up from 1.4% in Q4 20221 In Q1 2023 Spinach® ranked in the top-10 in all categories it participated in:...
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
February 28, 2023 07:30 ET
|
Cronos Group Inc.
Consolidated net revenue increased 23% in Full Year 2022 compared to Full Year 2021; on a constant currency basis consolidated net revenue increased 28% in Full Year 2022 compared to Full Year 2021 ...
Cronos Group Inc. to Hold 2022 Fourth Quarter and Full-Year Earnings Conference Call on February 28, 2023
February 14, 2023 09:25 ET
|
Cronos Group Inc.
TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 fourth quarter and full-year earnings conference call on...
Spinach® Becomes the Number One Edible Brand in January¹
February 08, 2023 07:30 ET
|
Cronos Group Inc.
Spinach® gummies, known for incredible flavors and quality, are winning with adult consumers in the Canadian market TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX:...
Cronos Group Inc. Announces Receipt of Notice of Relinquishment of Warrant by Altria
December 19, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that on December 16, 2022, Altria Group, Inc. (“Altria”) notified...
Cronos Unveils its New CBC Product: Spinach FEELZ™ Day Trip Gummies With THC+CBC
December 07, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced the launch of a CBC-focused product, the...
Cronos Group Inc. to Speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference
November 29, 2022 16:35 ET
|
Cronos Group Inc.
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein,...
Cronos Group Appoints James Holm as Chief Financial Officer
November 14, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of...
Cronos Group Reports 2022 Third Quarter Results
November 07, 2022 07:30 ET
|
Cronos Group Inc.
Reported consolidated net revenue increased 3% year-over-year to $20.9 million; on a constant currency basis, consolidated net revenue increased 7% year-over-year to $21.8 million Reported net...